Muhammad Zafar, MD
Clinical Neurophysiology · Durham, NCNPI 1790018000
Payments from drug & device makers
Across 678 payments — averaging $4120.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- SK Life Science, Inc.$1.2M
- Livanova USA, Inc.$521K
- Eisai Inc.$335K
- UCB SA$275K
- Jazz Pharmaceuticals Inc.$198K
- Immedica Pharma US, Inc.$180K
- plus $130K from 20 others
Across 2 payments — averaging $24,519 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurelis, Inc.$35K
- Immedica Pharma US, Inc.$14K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| SK Life Science, Inc. | 196 | $1,155,438 |
| Livanova USA, Inc. | 181 | $520,631 |
| Eisai Inc. | 76 | $335,243 |
| UCB SA | 23 | $275,132 |
| Jazz Pharmaceuticals Inc. | 39 | $197,906 |
| Immedica Pharma US, Inc. | 39 | $179,769 |
| Neurelis, Inc. | 15 | $71,623 |
| Neurocrine Biosciences, Inc. | 45 | $14,503 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $9,031 |
| GW Research Limited | 1 | $8,585 |
| Biocodex, Inc. | 8 | $6,138 |
| Mallinckrodt Enterprises LLC | 9 | $5,357 |
| Aquestive Therapeutics, Inc. | 5 | $4,300 |
| UCB, Inc. | 9 | $2,951 |
| PTC Therapeutics, Inc. | 2 | $2,700 |
| Acadia Pharmaceuticals Inc | 1 | $2,200 |
| Monteris Medical Corporation | 8 | $1,031 |
| Vertex | 2 | $750 |
| Greenwich Biosciences, Inc. | 1 | $138 |
| Sunovion Pharmaceuticals Inc. | 1 | $123 |
| Biomarin Pharmaceutical Inc. | 1 | $87 |
| Pyros Pharmaceuticals, Inc. | 1 | $83 |
| Sumitomo Pharma America, Inc. | 1 | $79 |
| Neuropace, Inc. | 1 | $79 |
| Zogenix Inc. | 1 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $26 |
How this compares
Too few clinical neurophysiology providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical neurophysiology in Durham
- Matthew LuedkeDurham$7K
- Vishal MandgeDurham$4K
- James CaressWinston Salem$443K
- Jane BoggsWinston Salem$131K
- Christa SwisherCharlotte$39K
- Adrian HadionoConcord$2K
- Christopher ConnellyConcord$431
- Jennifer ZuroskyCharlotte$404
- Betty StewartHendersonville$54
- Prabhu EmmadyConcord$54
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.